Achieve Robust Diversification With These 3 Equal-Weight ETFs Equal-weight ETFs like RSP, QQEW, and DFVE offer alternatives to market-cap-weighted funds, providing more balanced exposure across holdings with 2026 YTD returns near 12-13%.
ISCG vs. RZG: Which Small-Cap Growth ETF Is the Better Buy for Investors? ISCG offers lower fees and broader diversification, while RZG's portfolio strategy has outperformed over the past five years
Nothing Is Perfect: The Pros and Cons of Index Funds As popular as index funds are, they have a few shortcomings.
1 ETF That Has Quietly Beaten the S&P 500 for a Decade Nearly 5 extra percentage points a year, compounded over a decade, is a life-changing difference.
What This Invesco Insider Move Signals With the Stock Up 63% The shares were withheld to cover tax liabilities from restricted stock unit vesting.
If I Could Tell Every QQQ Investor 1 Thing About SpaceX's Nasdaq-100 Entry, It's This Anyone expecting SpaceX to become a huge holding in the Nasdaq-100 index is likely going to be disappointed.
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)? IBBQ surged 54.5% in one year but carries deeper drawdowns. XLV offers broader diversification, lower costs, and double dividend yield for steadier returns.
Which Is the Better Consumer Staples ETF, Vanguard's VDC or Invesco's RSPS? VDC's market-cap approach favors giants like Walmart, while RSPS equally weights 34 stocks for different risk exposure.
PPA vs ARKX Aerospace ETF Showdown: Which ETF Is the High Flier for 2026? One targets traditional defense contractors with lower costs; other pursues speculative space tech with higher volatility. Which fits your portfolio?
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? PJP delivers lower volatility and higher income with concentrated pharma exposure, while XBI offers broader biotech growth at lower cost.
Best 3 Dividend ETF Picks for the Second Half of 2026 Dividend stocks have enjoyed a strong first half of 2026. Conditions still look favorable, which could propel these three ETFs in particular.
Tech Stock Sell-Off: 1 ETF to Load Up On Right Now The Invesco QQQ Trust is a top ETF to buy on the tech dip.
Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? PJP delivered stronger 5-year returns with lower volatility, while FBT offers broader biotech exposure at a slightly cheaper cost.
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH? IBBQ offers lower costs and broader diversification, while XPH delivered stronger 1-year returns with less volatility.
Invesco's CFO Laura Dukes Sells About 52,00 Shares Dukes' sale was non-discretionary. She retains ~290,000 shares valued at $8.1 million.
How to Find Out If Your 401(k) Already Holds SpaceX Stock Over the next several years, more and more 401(k) accounts will likely have exposure to SpaceX.
VOO vs. QQQ: Which Index Fund Is the Better Buy for Long-Term Investors? QQQ delivered better returns over the past five years, but also suffered a higher maximum drawdown. VOO offers lower fees and a higher dividend for more conservative investors.
SpaceX Is Joining the Nasdaq-100 This Week. What This Means for Invesco QQQ Investors. SpaceX is joining the Nasdaq-100 this week, giving Invesco QQQ Trust investors indirect exposure to the stock.
Want to Own SpaceX Stock? Here Are 3 Things Investors Should Know Right Now As major indexes add SpaceX, you may already have a small amount of the space stock in your portfolio.
Which Is the Better Long-Term Buy: iShares' Small-Cap IWM or Invesco's Tech-Heavy QQQ? QQQ has dominated the past decade, while IWM is still waiting for its turn. Here is how to decide which one belongs in your portfolio.
The Stock Market Will Make History on July 7. Here's What Investors Need to Know Now. SpaceX will be the first mega-IPO stock to join the Nasdaq-100 under its new fast-track entry rules.
